Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hoerni

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Bordeaux Medical|May 1, 1970
[Bases of the treatment of Hodgkin's disease. Pretherapeutic report]B Hoerni, J Chauvergne, A Le Treut, et al.
La Nouvelle Presse Medicale|September 8, 1973
[Chemotherapy of reticulosarcomas. Results of a controlled trial on 60 patients]J Chauvergne, B Hoerni, M Durand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Semen analysis and cryoconservation before treatment in Hodgkin's diseaseFitoussi, H Eghbali, N Tchen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single centerP Soubeyran, H Eghbali, M Trojani, et al.
Annales De Medecine Interne|April 1, 1975
[Infectious complications of malignant lymphomas. Evaluation of 411 infections observed in 629 patients]M Durand, B Hoerni, J Y Lacut, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1982
Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term responseJ Robert, A Illiadis, B Hoerni, et al.
Bulletin Du Cancer|January 1, 1981
[Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)]J Chauvergne, M Durand, R Brunet, et al.
Diagnostic and Clinical Immunology|January 1, 1988
Interleukin-2 receptor is functionally linked with in vitro activation of B cells isolated from non-Hodgkin's lymphomasO Garraud, E LeGrand, H Eghbali, et al.
Bulletin Du Cancer|January 1, 1975
[Significance of chemotherapy complementary to radiotherapy in stages I and II in Hodgkin's disease]C Lagarde, J Chauvergne, M Durand, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 9, 1982
[Treatment of inflammatory breast cancer. Controlled study of a combination therapy program]J Chauvergne, M Durand, M H Dilhuydy, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Bordeaux Medical|May 1, 1970
[Bases of the treatment of Hodgkin's disease. Pretherapeutic report]B Hoerni, J Chauvergne, A Le Treut, et al.
La Nouvelle Presse Medicale|September 8, 1973
[Chemotherapy of reticulosarcomas. Results of a controlled trial on 60 patients]J Chauvergne, B Hoerni, M Durand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2000
Semen analysis and cryoconservation before treatment in Hodgkin's diseaseFitoussi, H Eghbali, N Tchen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single centerP Soubeyran, H Eghbali, M Trojani, et al.
Annales De Medecine Interne|April 1, 1975
[Infectious complications of malignant lymphomas. Evaluation of 411 infections observed in 629 patients]M Durand, B Hoerni, J Y Lacut, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1982
Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term responseJ Robert, A Illiadis, B Hoerni, et al.
Bulletin Du Cancer|January 1, 1981
[Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)]J Chauvergne, M Durand, R Brunet, et al.
Diagnostic and Clinical Immunology|January 1, 1988
Interleukin-2 receptor is functionally linked with in vitro activation of B cells isolated from non-Hodgkin's lymphomasO Garraud, E LeGrand, H Eghbali, et al.
Bulletin Du Cancer|January 1, 1975
[Significance of chemotherapy complementary to radiotherapy in stages I and II in Hodgkin's disease]C Lagarde, J Chauvergne, M Durand, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|September 9, 1982
[Treatment of inflammatory breast cancer. Controlled study of a combination therapy program]J Chauvergne, M Durand, M H Dilhuydy, et al.
Pageof 23